nanoparticles. Based on characterization of the ECA matrix by biomimetic analyses, this novel collagen-based biotextile may serve as a promising pelvic fascial substitute material for slings and reconstructive surgery. These findings support further experimentation of adding other nano-particles and cross-linking manufacturing steps to further enhance the balance between additional biomechanical and biocompatibility features. Cold stress produced by sudden change or continuous exposure to low temperature exacerbates lower urinary tract symptoms (LUTS), such as urinary urgency, frequency, and nocturia. Stimulation of C-fibers and TRPM8 channels have been reported as mechanisms of cold stress related LUTS. Daiken-chu-tou, a chinese herbal medicine has been traditionally used for improvement of bowel conditions. In basic research, dai-ken-chu-tou has been reported to influence intestinal tracts by decreasing adrenomeduline and decreasing the stimulation of the pathway of TRPV1 and TRPA1, which are also important pathways with bladder function. We examined whether dai-ken-chu-tou improves cold stress related LUTS in rats.
INTRODUCTION AND OBJECTIVES:
Cold stress produced by sudden change or continuous exposure to low temperature exacerbates lower urinary tract symptoms (LUTS), such as urinary urgency, frequency, and nocturia. Stimulation of C-fibers and TRPM8 channels have been reported as mechanisms of cold stress related LUTS. Daiken-chu-tou, a chinese herbal medicine has been traditionally used for improvement of bowel conditions. In basic research, dai-ken-chu-tou has been reported to influence intestinal tracts by decreasing adrenomeduline and decreasing the stimulation of the pathway of TRPV1 and TRPA1, which are also important pathways with bladder function. We examined whether dai-ken-chu-tou improves cold stress related LUTS in rats.
METHODS: A total of 22 Sprague-Dawley rats at postnatal week 10 were used in the experiments. The animals sere randomly divided into 2 gtoups, which were kept with Dai-ken-chu-tou-including food (2700mg/kg) or normal food for 4 weeks. After 4 weeks, cystometography (CMG) was performed under awake condition. CMG was first performed in room temperature (RT) for 20 minuets. Rats were then put into low temperature (LT) for 40 minutes. After LT, rats were put into RT for 20 minutes. After CMG, the whole bladder was removed and real time PCR was performed.
RESULTS: Results of the CMG are shown in Fig 1. Basal pressure and micturition pressure did not show a difference between control rats and Dai-ken-chu-tou rats, but change rate with cold stress in voiding interval and micturition volume did show a significant difference. Results of real time PCR are shown in Fig 2. Significant decrease of P2X3, TRPV1, and TRPM8 in the bladder was seen in Dai-ken-chutou rats.
CONCLUSIONS: Dai-ken-chu-tou improved cold stress related frequency in rats. Down regulation of P2X3, TRPV1 and TRPM8 may have a relation with the improvement in cold stress related frequency in rats.
Source of Funding: none

MP26-05 RELAXING EFFECT OF PHOSPHODIESTERASE INHIBITORS AND b3-ADRENOCEPTOR AGONIST IN AN EXPERIMENTAL MODEL OF DETRUSOR OVERACTIVITY
Bruno Lima Linhares*, Lúcio F. Gonzaga-Silva, Rommel P. Regadas, Lucas B. Marinho, João B. G. Cerqueira, Manoel O. Moraes Filho, Cláudia F. Santos, Nilberto R. F. Nascimento, Ricardo Reges, Fortaleza, Brazil INTRODUCTION AND OBJECTIVES: Overactivity bladder syndrome has classically been treated with antimuscarinics. Frequent adverse systemic effects have led to the search for new therapeutic options. b3-adrenoceptor (b3-AR) agonists relax the detrusor smooth muscle (DSM) by the adenylyl cyclase pathway, increasing cAMP. Rolipram, a selective type 4 phosphodiesterase inhibitor (PDE4i), elevates cAMP levels by supressing hydrolysis. Phosphodiesterase type 5 inhibitors (PDE5i), such as tadalafil, relax DSM by the nitric oxide (NO)/ cGMP pathway. It has been hypothesized that the inhibition of phophodiesterases could potentiate the relaxing effect of b3-AR agonists. The main objective of this study is to evaluate in vitro the effects of the combination of a b3-AR agonist with two different phophodiesterase e320 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 (PDE) inhibitors (PDE4i and PDE5i) in an experimental model of detrusor overactivity. METHODS: The experiments were performed on bladder strips of mice treated with L-NAME for 30 days. Chronic L-NAME administration leads to detrusor overactivity by NO deprivation. The following drugs were used: BRL 37344 (b3-AR agonist), tadalafil (PDE5i) and rolipram (PDE4i). After potassium-induced contraction, strips isolated from mice were exposed to increasing concentrations of each drug. In another series of experiments, prior to contraction, strips were incubated with either tadalafil or rolipram and then increasing concentrations of BRL 37344 were added.
RESULTS: Cumulative concentration-response curves were constructed. Rolipram showed the best relaxation when compared to the other drugs (Figure 1) . Rolipram increased the relaxing response of BRL 37344 in almost all concentrations, but no synergistic effect with tadalafil was observed (Figure 2) . CONCLUSIONS: PDE inhibitors associated with the already proven effective b3-AR agonists may represent a new approach for patients with storage symptons. The relaxing effect of the b3-AR agonist was potentiated by PDE4i but not by PDE5i, suggesting cAMP plays an important role in DSM relaxation.
Source of Funding: none
MP26-06 NON-HUMAN PRIMATE (NHP) MODEL OF URINARY INCONTINENCE AND ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY
Joao Zambon*, Manish Patel, Ashok Hemal, Gopal Badlani, Ashley Dean, Shannon Lankford, Koudy Williams, Winston-Salem, NC INTRODUCTION AND OBJECTIVES: Prevention of urinary incontinence (UI) and erectile dysfunction (ED) during healing following radical prostatectomy is poorly understood. A reproducible animal model that mimics human anatomy such as intrapelvic bladder, similar genitourinary system, an upright posture with ability to simulate the radical prostatectomy was the first step. Second, was to develop a reproducible, subjectively and objectively quantifiable, model of UI and ED after open radical prostatectomy (ORP) using Cynomologus monkeys at the age equivalent to middle aged men.
METHODS: Ten monkeys were used; two for the anatomical study & feasibility of doing ORP and eight underwent ORP. Animals were sacrificed at 6 months follow up. UI was evaluated through, observed voiding behavior, & urodynamics performed before, 3 and 6 months after ORP. At 3 and 6 months postop, phenazopyridine was added to their juice to demonstrate observed urinary leakage. Erectile Function was assessed before, 3 and 6 months after ORP by intracavernosal (IC) pressure measurement after IC papaverine injection. Sexual behavior was video-monitored at the same time points. The following parameters were analyzed: mounting, thrusting and erection. CT scan was done at 3 and 6 months postop to evaluate urethral anastomosis. After being sacrificed specimens were collected for histology.
RESULTS: At 3 (N¼8) and 6 (N¼4) months after ORP all monkeys had UI and ED. There was a statistically significant decrease in abdominal leak point pressure (Table 1 ) at 3 & 6 months follow up, and a decline in the IC pressure after IC injection (Graph 1). Animals were not able to achieve erection when placed with a female partner. CT scan showed intact bladder-urethral anastomosis and Mason trichrome staining demonstrated peri-urethral fibrosis.
CONCLUSIONS: This is the first reported long-term NHP model of UI and ED after open radical prostatectomy. This model can help in developing new strategies for prevention and treatment with novel approaches.
